Neonatal FormularyPub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0034
Sean Ainsworth
{"title":"V","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0034","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0034","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with V, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Vancomycin, Varicella-zoster immunoglobulin and vaccine, Vasopressin, desmopressin, and terlipressin, Vigabatrin, Vitamin A (retinol), Vitamin B12 (hydroxocobalamin), Vitamin D (special formulations), Vitamin D (standard formulations), Vitamin E (alpha tocopherol), Vitamin K1 = phytomenadione (rINN), phytonadione (USAP), and Vitamins (multi-vitamins)","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78789818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neonatal FormularyPub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0024
Sean Ainsworth
{"title":"L","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0024","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0024","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with L, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Labetalol hydrochloride, Lactoferrin, Lamivudine, Lamotrigine, Lansoprazole, Levetiracetam, Levosimendan, Levothyroxine sodium, Lidocaine = Lignocaine (former BAN), Linezolid, Lipid emulsions for parenteral nutrition, Loperamide, Lopinavir with ritonavir, Lorazepam, and Low-molecular-weight heparins and other anticoagulants","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82866466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neonatal FormularyPub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0015
Sean Ainsworth
{"title":"B","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0015","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0015","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with B, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of BCG (Bacillus Calmette– Guérin) vaccine, Betaine, Betamethasone, Biotin, Blood, Bosentan, Breast milk fortifiers, Budesonide, and Bupivacaine","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87417763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neonatal FormularyPub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0018
Sean Ainsworth
{"title":"E","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0018","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0018","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with E, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Enemas, laxatives, and suppositories, Enoxaparin, Enzyme replacement therapy, Epoetin (recombinant human erythropoietin = rEPO), Epoprostenol and other prostanoids (iloprost and teoprostinil), Erythromycin, Esomeprazole, Ethambutol, and Eye drops (and ointments)","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"78 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80266867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neonatal FormularyPub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0025
Sean Ainsworth
{"title":"M","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0025","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0025","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with M, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Magnesium sulfate (Magnesium sulphate = former BAN), Mebendazole, Mefloquine, Melatonin, Meningococcal vaccines, Mercaptamine (Cysteamine— former BAN), Meropenem, Methadone, Methyldopa, Methylthioninium chloride (Methylene blue = former BAN), Metoclopramide, Metronidazole, Micafungin, Miconazole, Midazolam, Formula milk thickeners and anti-reflux milks, Milrinone, Misoprostol, Mivacurium, Morphine, and Mupirocin","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73678912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neonatal FormularyPub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0026
Sean Ainsworth
{"title":"N","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0026","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0026","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with N, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Naloxone, Neostigmine (and pyridostigmine), Nevirapine, Nifedipine, Nitazoxanide, Nitisinone, Nitric oxide, Nitrofurantoin, Nitrous oxide, Noradrenaline = Norepinephrine (rINN), and Nystatin","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83165875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
求助内容：
应助结果提醒方式：